Ulrik Mørch

Ulrik Mørch is a highly accomplished professional in global medical affairs, specializing in inflammation and anti-fungals. With more than a decade of experience, Ulrik most recently served as the Global Head of Medical Affairs at Gilead, where they led strategy development and data generation efforts. Previously, Ulrik held significant roles at AbbVie and Novo Nordisk, contributing expertise in gastroenterology and clinical development. Ulrik holds an Executive Medical Master of Business Strategy from CBS Executive and a Ph.D. in Immunology from the University of Copenhagen.